Shenzhen Hepalink Pharmaceutical Co Ltd (002399) — Financial Flexibility Index

Latest as of September 2025: 0.09x

Shenzhen Hepalink Pharmaceutical Co Ltd (002399) has a Financial Flexibility Index of 0.09x as of September 2025. Free cash flow of CN¥413.04 Million (operating CF CN¥399.43 Million minus capex CN¥13.60 Million) represents 0% of total liabilities (CN¥4.70 Billion). Also explore Shenzhen Hepalink Pharmaceutical Co Ltd net asset momentum to track the company's year-over-year net asset growth rate.

Financial Flexibility Index

0.09x
Free Cash Flow / Total Liabilities

Free Cash Flow

CN¥413.04 Million
Operating CF − Capex

Total Liabilities

CN¥4.70 Billion
CNY

Capital Expenditures

CN¥13.60 Million
CNY

Shenzhen Hepalink Pharmaceutical Co Ltd Financial Flexibility Index (2006–2025)

Historical Financial Flexibility Index trend for Shenzhen Hepalink Pharmaceutical Co Ltd across 20 annual periods. Check how strategically is Shenzhen Hepalink Pharmaceutical Co Ltd's equity deployed to assess the company's strategic physical and investment asset allocation.

Annual Financial Flexibility Index for Shenzhen Hepalink Pharmaceutical Co Ltd (2006–2025)

Year-by-year free cash flow to debt coverage for Shenzhen Hepalink Pharmaceutical Co Ltd. For the full company profile including market capitalisation, see 002399 company net worth.

Year Flexibility Index Free Cash Flow (CNY) Operating CF Total Liabilities YoY Change
2025 0.40x CN¥1.83 Billion CN¥1.71 Billion CN¥4.55 Billion ▼ -13.6%
2024 0.47x CN¥2.40 Billion CN¥2.19 Billion CN¥5.14 Billion ▲ +299.0%
2023 0.12x CN¥843.09 Million CN¥398.22 Million CN¥7.22 Billion ▲ +283.9%
2022 -0.06x CN¥-534.19 Million CN¥-756.61 Million CN¥8.41 Billion ▼ -357.4%
2021 0.02x CN¥187.23 Million CN¥-6.63 Million CN¥7.58 Billion ▼ -27.5%
2020 0.03x CN¥249.77 Million CN¥37.28 Million CN¥7.34 Billion ▲ +96.7%
2019 0.02x CN¥134.47 Million CN¥-227.60 Million CN¥7.77 Billion ▼ -89.3%
2018 0.16x CN¥1.20 Billion CN¥667.87 Million CN¥7.41 Billion ▲ +428.5%
2017 0.03x CN¥169.01 Million CN¥-407.12 Million CN¥5.50 Billion ▼ -79.0%
2016 0.15x CN¥705.61 Million CN¥346.07 Million CN¥4.83 Billion ▼ -53.5%
2015 0.31x CN¥1.06 Billion CN¥893.71 Million CN¥3.38 Billion ▼ -54.0%
2014 0.68x CN¥1.08 Billion CN¥912.80 Million CN¥1.58 Billion ▼ -80.5%
2013 3.51x CN¥714.94 Million CN¥420.97 Million CN¥203.80 Million ▲ +5.8%
2012 3.32x CN¥711.44 Million CN¥473.89 Million CN¥214.53 Million ▼ -87.1%
2011 25.67x CN¥1.54 Billion CN¥1.41 Billion CN¥59.98 Million ▲ +579.3%
2010 3.78x CN¥390.80 Million CN¥354.86 Million CN¥103.44 Million ▲ +181.8%
2009 1.34x CN¥410.72 Million CN¥355.81 Million CN¥306.33 Million ▲ +613.5%
2008 0.19x CN¥50.94 Million CN¥40.13 Million CN¥271.09 Million ▼ -18.9%
2007 0.23x CN¥25.80 Million CN¥13.85 Million CN¥111.28 Million ▼ -27.5%
2006 0.32x CN¥82.36 Million CN¥71.66 Million CN¥257.68 Million —
Financial Flexibility Index = (Operating CF − Capex) / Total Liabilities = Free Cash Flow / Total Liabilities